Product Images Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Hydrochlorothiazide NDC 0172-2089 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

image 2

image 2

This is a description of Hydrochlorothiazide, an RX only drug which comes in tablet form. It contains 25 mg of hydrochlorothiazide, USP. The package insert contains information about the drug's dosing information. It is to be stored at a temperature of 20 to 25 degrees Celsius. The tablet container requires child-resistant closure. Teva Czech Industries manufactures it in the Czech Republic for Teva Pharmaceuticals, based in New Jersey. The text also includes a serialization coding area which contains a serialized number.*

image 3

image 3

This is a description for Hydrochlorothiazide Tablets, USP. Each tablet contains 50mg of hydrochlorothiazide. The usual dosage information can be found in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F). They should be dispensed in a well-closed container and kept out of the reach of children. The manufacturer is Teva Czech, located in Opava-Komarov, Czech Republic. The medication is manufactured for Teva Pharmaceuticals in Parsippany, NJ, and has a National Drug Code of 0172-2089-60 and a Global Trade Item Number of 00301722089602. The description also includes a Revision Date of 3/2022 and a serialization coding area.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.